Editorial: La Vanguardia

• Researchers from Vall d’Hebron Instituto de Oncología and Instituto Hospital del Mar de Investigaciones Médicas have developed a new breast cancer therapy.
• This therapy is based on the genetic modification of immune cells (CAR-T) so that they recognize and exclusively attack cancer cells, along with bio-specific antibodies.
• The therapy is only effective, to this date, to treat tumors with an excess of HER2 protein.
• The new therapy also showed efficacy against tumors in other parts of the body with excess HER2 protein.
• Barcelona, where the discovery took place, is the second health sciences bioregion in Europe.
• The text mentions the need for strategies to attract more talent and improve the healthcare sector prospects.

Conclusion: This new discovery strengthens Barcelona's position as a leading center in biomedical research and offers new hope in the fight against cancer.

---